N/A
N=4,812
A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Glaucoma, Open-Angle · Ocular Hypertension
Bottom Line
View on ClinicalTrials.gov: NCT01628614 ↗Enrolled (actual)
4,812
Serious AEs
0.0%
Results posted
Sep 2012
Primary outcome: Primary: Percentage of Patients With a Reduction in Intraocular Pressure (IOP) ≥ 5mmHg From Baseline — 75.9 Millimeters of Mercury (mmHg)
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Standard of Care (Other)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Allergan
- Primary completion
- Jul 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Patients With a Reduction in Intraocular Pressure (IOP) ≥ 5mmHg From Baseline |
75.9 | — |
| SECONDARY Percentage of Patients With an IOP Reduction ≥10% From Baseline |
91.0 | — |
| SECONDARY Percentage of Patients With an IOP Reduction ≥20% From Baseline |
70.8 | — |
Summary
This is an observational study and will evaluate IOP reduction in newly diagnosed patients with POAG or OHT. All care (including treatment and diagnostic procedures) provided is at the discretion of the participating physicians according to their clinical judgment and the local standard of medical care.
Eligibility Criteria
Inclusion Criteria
- Newly diagnosed with primary open angle glaucoma or ocular hypertension
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT01628614). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.